VIRAL PARTICLE RELEASED AFTER INFECTION OF MAMMALIAN CELLS BY HUMAN CYTOMEGALOVIRUS (HCMV) CONTAINING A FUSION PROTEIN AND USE THEREOF
    2.
    发明申请
    VIRAL PARTICLE RELEASED AFTER INFECTION OF MAMMALIAN CELLS BY HUMAN CYTOMEGALOVIRUS (HCMV) CONTAINING A FUSION PROTEIN AND USE THEREOF 有权
    包含融合蛋白的人类细胞病毒(HCMV)感染马氏体细胞后发现的病毒粒子及其用途

    公开(公告)号:US20130202708A1

    公开(公告)日:2013-08-08

    申请号:US13639636

    申请日:2011-04-06

    IPC分类号: A61K39/245

    摘要: The present invention is related to a viral particle released after infection of mammalian cells by human cytomegalovirus (HCMV), wherein a) the particle is surrounded by a lipid membrane in which viral glycoproteins are embedded, b) the particle contains neither viral DNA nor capsids; and c) the particle contains a fusion protein comprising one or more parts of the T-cell antigen pp65 and at least one heterologous peptide, and wherein the at least one heterologous peptide is inserted at amino acid position W175 or A534 of the amino acid sequence of the T-cell antigen pp65.

    摘要翻译: 本发明涉及通过人巨细胞病毒(HCMV)感染哺乳动物细胞后释放的病毒颗粒,其中a)所述颗粒被其中包含病毒糖蛋白的脂质膜包围,b)所述颗粒不含病毒DNA和衣壳 ; 和c)所述颗粒含有包含T细胞抗原pp65的一个或多个部分和至少一个异源肽的融合蛋白,并且其中所述至少一个异源肽插入氨基酸序列的氨基酸位置W175或A534 的T细胞抗原pp65。

    HCMV VACCINE STRAIN
    4.
    发明申请

    公开(公告)号:US20210230228A1

    公开(公告)日:2021-07-29

    申请号:US16972249

    申请日:2019-06-28

    申请人: Bodo PLACHTER

    摘要: The present invention relates to nucleic acid molecules encoding a recombinant human cytomegalovirus (HCMV) strain, dense bodies produced by said HCMV strain and preparations of said dense bodies for use in medicine, particularly as a vaccine against HCMV.

    Viral particle released after infection of mammalian cells by human cytomegalovirus (HCMV) containing a fusion protein and use thereof
    5.
    发明授权
    Viral particle released after infection of mammalian cells by human cytomegalovirus (HCMV) containing a fusion protein and use thereof 有权
    通过含有融合蛋白的人巨细胞病毒(HCMV)感染哺乳动物细胞后释放的病毒颗粒及其用途

    公开(公告)号:US09486517B2

    公开(公告)日:2016-11-08

    申请号:US13639636

    申请日:2011-04-06

    IPC分类号: A61K39/245 C12N7/00 C12N15/86

    摘要: The present invention is related to a viral particle released after infection of mammalian cells by human cytomegalovirus (HCMV), wherein a) the particle is surrounded by a lipid membrane in which viral glycoproteins are embedded, b) the particle contains neither viral DNA nor capsids; and c) the particle contains a fusion protein comprising one or more parts of the T-cell antigen pp65 and at least one heterologous peptide, and wherein the at least one heterologous peptide is inserted at amino acid position W175 or A534 of the amino acid sequence of the T-cell antigen pp65.

    摘要翻译: 本发明涉及通过人巨细胞病毒(HCMV)感染哺乳动物细胞后释放的病毒颗粒,其中a)所述颗粒被其中包含病毒糖蛋白的脂质膜包围,b)所述颗粒不含病毒DNA和衣壳 ; 和c)所述颗粒含有包含T细胞抗原pp65的一个或多个部分和至少一个异源肽的融合蛋白,并且其中所述至少一个异源肽插入氨基酸序列的氨基酸位置W175或A534 的T细胞抗原pp65。